Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 892,"Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13.",central nervous system integrity trait,,RS:0002386,DA.PVG.1AV1-(D4Rat23-D4Mit12)/Kini,female,0 days,14,,CMO:0001422,post-insult time to onset of experimental autoimmune encephalomyelitis,,,,11.2,d,,,MMO:0000163,in vivo visual assessment,,0.0,from 8 to 40 days,subcutaneous injection,,,myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days),69416,myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) 892,"Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13.",central nervous system integrity trait,,RS:0002386,DA.PVG.1AV1-(D4Rat23-D4Mit12)/Kini,female,0 days,18,,CMO:0001422,post-insult time to onset of experimental autoimmune encephalomyelitis,,,,31.2,d,,,MMO:0000163,in vivo visual assessment,,0.0,from 8 to 34 days,subcutaneous injection,,,myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days),69429,myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days) 892,"Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13.",central nervous system integrity trait,,RS:0002386,DA.PVG.1AV1-(D4Rat23-D4Mit12)/Kini,female,0 days,14,,CMO:0001047,percentage of study population developing experimental autoimmune encephalomyelitis during a period of time,,,,86,%,,,MMO:0000163,in vivo visual assessment,,0.0,from 8 to 40 days,subcutaneous injection,40,days,myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days),69415,myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) 892,"Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13.",central nervous system integrity trait,,RS:0002386,DA.PVG.1AV1-(D4Rat23-D4Mit12)/Kini,female,0 days,14,,CMO:0001424,experimental autoimmune encephalomyelitis duration,,,,18.4,d,,,MMO:0000163,in vivo visual assessment,,0.0,from 8 to 40 days,subcutaneous injection,40,days,myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days),69417,myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) 892,"Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13.",central nervous system integrity trait,,RS:0002386,DA.PVG.1AV1-(D4Rat23-D4Mit12)/Kini,female,0 days,18,,CMO:0001424,experimental autoimmune encephalomyelitis duration,,,,6,d,,,MMO:0000163,in vivo visual assessment,,0.0,from 8 to 34 days,subcutaneous injection,34,days,myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days),69430,myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days)